High-Tech Gründerfonds invests in the medical technology of the future
Frankfurt a. M. — Kumovis develops 3D printers specifically for medical technology and enables with its technology, for example, the production of patient-adapted implants. HTGF is now participating in a seven-figure seed financing together with a family office and is thus supporting the company in the market launch of the innovative printers.
The founders of Kumovis GmbH, including managing director Dr.-Ing. Miriam Haerst (photo), have set themselves the goal of enabling the additive production of plastic implants and are developing innovative 3D printers for this purpose. The printers are specially tailored to medical technology requirements. The focus is on the processing of high-performance polymers, such as PEEK or PPSU, which are already established in medical technology and approved for the manufacture of medical devices. — The Munich-based high-tech startup has received a lot of encouragement from industry and the startup scene in recent months, and has won the Munich Business Plan Competition, for example.
Dr. Carsten Rudolph, Managing Director BayStartUP: “Kumovis offers a very good combination of digitalization and medical technology. In the three phases in the Munich Business Plan Competition this year, we could observe a strong development of the founders, and the team has systematically advanced its company.”
Thanks to the completed seed financing round in the seven-figure range with HTGF and a family office, the young company can now prepare its market entry.
About Kumovis GmbH
In October 2017, Kumovis GmbH was founded as a spin-off of the TU Munich. The founders developed the first idea for this in 2016 as part of their activities at the Chair of Medical Technology and were able to build and test the first prototypes with the support of the EXIST Forschungstransfer funding program and funding from ESA BIC Bavaria.